Quantcast

Latest Microbiome Stories

2014-10-24 16:25:46

Changing the gut microbiome to treat Clostridium difficile Infections HOUSTON, Oct. 24, 2014 /PRNewswire/ -- Metanome, Inc., a Houston-based provider of comprehensive metagenomic services and data analysis, was the genomic sequencing provider for Seres Health's (Cambridge, Mass) Phase I/II clinical trial of SER 109, an Ecobiotic® therapeutic for the treatment of patients with recurrent Clostridium difficile infections (CDI). Metanome has provided genomic sequencing services in...

2014-10-07 08:29:23

Mayo Clinic to Provide Clinical Expertise across Multiple Disease Indications SOUTH SAN FRANCISCO, Calif., Oct. 7, 2014 /PRNewswire/ -- Second Genome, Inc., a leader in the development of novel medicines through innovative microbiome science, has entered into an extensive partnership with the Mayo Clinic Center for Individualized Medicine to support the development of therapeutic products for multiple disease indications, starting with inflammatory bowel disease, metabolic...

2014-10-02 12:30:35

CARLSBAD, Calif., Oct. 2, 2014 /PRNewswire/ -- MO BIO Laboratories, Inc. is proud to announce the winners of the MO BIO Microbiome Awards, which provide young, extraordinary scientists with funding and recognition to carry out scientific work in the field of microbiome research. MO BIO is honored to partner with the EMP consortium to supply sample analysis, including nucleic acid extraction (using MO BIO products) and targeted amplicon analysis (16S rDNA) to this year's three...

2014-09-19 12:25:43

DUBLIN, Sept. 19, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 For the purposes of this report, the human microbiome market is segmented by application, disease, product, and geography. The human microbiome market is expected to be valued as $294 million in 2019 and...

2014-09-18 23:07:02

The human microbiome market is divided into three major segments, namely, application, disease, and product. http://www.marketsandmarkets.com/Market-Reports/human-microbiome-market-37621904.html (PRWEB) September 18, 2014 The "Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) –Global Forecast to 2023",...

2014-09-10 16:25:54

DALLAS, September 10, 2014 /PRNewswire/ -- According to the new market research report "Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Other Supplements, Device, Drug) - Global Forecast to 2023", published by MarketsandMarkets, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current...

2014-09-09 08:31:20

Former Pfizer Executive to Lead R&D at Second Genome SOUTH SAN FRANCISCO, Calif., Sept. 9, 2014 /PRNewswire/ -- Second Genome, Inc., a leader in the development of novel medicines through innovative microbiome science, announced today that it has appointed Karim Dabbagh, Ph.D., as the company's Chief Scientific Officer. In this new position, Dr. Dabbagh will be responsible for the company's drug pipeline, fueled by Second Genome's novel discovery platform for identifying and...

2014-09-08 16:25:18

Phase I/II study also demonstrated SER-109 restoration of a diverse, healthy microbiome CAMBRIDGE, Mass., Sept. 8, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel treatments for diseases related to the human microbiome, today announced final data for its single-arm, open-label clinical trial of SER-109, its first-in-field, oral microbiome therapeutic. SER-109, a mixture of bacterial spores, is designed for the treatment of recurrent...

2014-08-28 12:29:24

CAMBRIDGE, Mass., Aug. 28, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel treatments for diseases related to the human microbiome, announced today that Dr. David Cook, Seres' Executive Vice President of R&D and Chief Scientific Officer, will be presenting at the 2014 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The presentation will highlight the scientific and medical implications of SER-109, a novel mixture...

cravings and bacteria
2014-08-18 05:00:59

April Flowers for redOrbit.com - Your Universe Online Our bodies play host to millions of bacteria. In fact, they outnumber our own cells by about 100-fold. And yet, we hold the notion that we are in charge of our own lives, not the bacteria that has just hitched a ride. A new study, published in BioEssays, tells a different story. The findings reveal that the bacteria within our bodies may very well be affecting our cravings and our moods to ensure that we eat what they want. The...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related